Tech Company Financing Transactions

Logical Therapeutics Funding Round

Logical Therapeutics, based in Foxboro, secured $16.9 million in investment from SV Health Investors, Burrill & Company and Novitas Capital.

Transaction Overview

Company Name
Logical Therapeutics
Announced On
5/27/2010
Transaction Type
Venture Equity
Amount
$16,900,000
Round
Series C
Investors

SV Health Investors (Lead Investor) (Lutz Giebel)

Burrill & Company (Bryant Fong)

Novitas Capital (Paul Schmitt)

Novo Ventures (Martin Edwards)

Proceeds Purpose
The Series C financing round is expected to provide sufficient capital to advance the Company's development program through further clinical and non-clinical activities necessary for registration. The Company intends to seek a business partner prior to commercialization.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
124 Washington St. 101
Foxboro, MA 02035
USA
Phone
(781) 290-0900
Website
www.logicaltherapeutics.com
Email Address
[email protected]
Overview
The company is developing medicines to treat diseases that are associated with poorly controlled or excessive inflammation.
Profile
Logical Therapeutics LinkedIn Company Profile
Social Media
Logical Therapeutics Company Twitter Account
Company News
Logical Therapeutics News
Facebook
Logical Therapeutics on Facebook
YouTube
Logical Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Co-Founder
Lutz Giebel
  Lutz Giebel LinkedIn Profile  Lutz Giebel Twitter Account  Lutz Giebel News  Lutz Giebel on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/27/2010: Teranetics venture capital transaction
Next: 5/28/2010: RealDirect venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.